Literature DB >> 32374445

Antibiotics and proton pump inhibitors suppress the efficacy of immunotherapy against non-small cell lung cancer.

Xiayao Diao1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32374445      PMCID： PMC7327691          DOI： 10.1111/1759-7714.13470

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN： 1759-7706            Impact factor:   3.500


× No keyword cloud information.
  16 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Comment on the paper 'Boffetta et al. Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy. Ann Oncol 2018; 29(2): 484-489'.

Authors:  D Consonni; C Mensi
Journal:  Ann Oncol       Date:  2019-02-01       Impact factor: 32.976

Review 3.  The biology and management of non-small cell lung cancer.

Authors:  Roy S Herbst; Daniel Morgensztern; Chris Boshoff
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

4.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

Review 5.  The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.

Authors:  Vancheswaran Gopalakrishnan; Beth A Helmink; Christine N Spencer; Alexandre Reuben; Jennifer A Wargo
Journal:  Cancer Cell       Date:  2018-04-09       Impact factor: 31.743

Review 6.  Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.

Authors:  Muhammad Khan; Jie Lin; Guixiang Liao; Yunhong Tian; Yingying Liang; Rong Li; Mengzhong Liu; Yawei Yuan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

Review 7.  Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.

Authors:  Jean-François Rossi; Patrice Céballos; Zhao-Yang Lu
Journal:  Cancer Commun (Lond)       Date:  2019-06-14

8.  Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Authors:  Rui-Mei Feng; Yi-Nan Zong; Su-Mei Cao; Rui-Hua Xu
Journal:  Cancer Commun (Lond)       Date:  2019-04-29

9.  Proton pump inhibitors affect the gut microbiome.

Authors:  Floris Imhann; Marc Jan Bonder; Arnau Vich Vila; Jingyuan Fu; Zlatan Mujagic; Lisa Vork; Ettje F Tigchelaar; Soesma A Jankipersadsing; Maria Carmen Cenit; Hermie J M Harmsen; Gerard Dijkstra; Lude Franke; Ramnik J Xavier; Daisy Jonkers; Cisca Wijmenga; Rinse K Weersma; Alexandra Zhernakova
Journal:  Gut       Date:  2015-12-09       Impact factor: 23.059

Review 10.  Precision medicine becomes reality-tumor type-agnostic therapy.

Authors:  Li Yan; Wei Zhang
Journal:  Cancer Commun (Lond)       Date:  2018-03-31
View more
  3 in total

1.  The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Authors:  Da-Hai Hu; Wan-Ching Wong; Jia-Xin Zhou; Ji Luo; Song-Wang Cai; Hong Zhou; Hui Tang
Journal:  J Oncol       Date:  2022-07-09       Impact factor: 4.501

2.  Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect.

Authors:  Kenta Yagi; Marin Mitstui; Yoshito Zamami; Takahiro Niimura; Yuki Izawa-Ishizawa; Mitsuhiro Goda; Masayuki Chuma; Kimiko Fukunaga; Takahiro Shibata; Shunsuke Ishida; Takumi Sakurada; Naoto Okada; Hirofumi Hamano; Yuya Horinouchi; Yasumasa Ikeda; Hiroaki Yanagawa; Keisuke Ishizawa
Journal:  Cancer Med       Date:  2020-11-24       Impact factor: 4.452

Review 3.  Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.

Authors:  Alessandro Rizzo; Antonio Cusmai; Francesco Giovannelli; Silvana Acquafredda; Lucia Rinaldi; Andrea Misino; Elisabetta Sara Montagna; Valentina Ungaro; Mariagrazia Lorusso; Gennaro Palmiotti
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.